BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:HCW Biologics Inc. (HCWB) investor events
X-WR-CALNAME:HCW Biologics Inc. (HCWB) investor events
DESCRIPTION:Earnings calls and investor events for HCW Biologics Inc. (HCWB
 )\, from Equibles.
X-WR-CALDESC:Earnings calls and investor events for HCW Biologics Inc. (HCW
 B)\, from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:8e644cd9-deb1-421d-b7ee-0b7702e37d50@equibles.com
DTSTAMP:20260617T190836Z
DTSTART;VALUE=DATE:20251107
DTEND;VALUE=DATE:20251108
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:HCW Biologics Inc. (HCWB) Earnings Call\, FY2025 Q3
DESCRIPTION:The start time has not been announced.\nWebcast: https://invest
 ors.hcwbiologics.com/events/event-details/debut-hcwbs-2nd-gen-t-cell-engag
 er-ind-enabling-study-data-40th-sitc2025
URL:https://equibles.com/stocks/hcwb/calls/2025-q3
END:VEVENT
BEGIN:VEVENT
UID:6caa5ba9-32d3-4afb-8236-8e09149a7058@equibles.com
DTSTAMP:20260617T191053Z
DTSTART;VALUE=DATE:20260331
DTEND;VALUE=DATE:20260401
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:HCW Biologics Inc. (HCWB) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:41ceb97e-1ae8-4b5d-bf56-9c7650119de6@equibles.com
DTSTAMP:20260624T233112Z
DTSTART;VALUE=DATE:20260420
DTEND;VALUE=DATE:20260421
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:HCW Biologics Inc. (HCWB) Annual General Meeting: Development of HC
 W11-018b (T Cell Engager)\, An Innovative Approach to Improve Bispecific T
 -Cell Engagers for Solid Tumor Therapy (Poster presented at AACR Annual Me
 eting 2026)
DESCRIPTION:Development of HCW11-018b (T Cell Engager)\, An Innovative Appr
 oach to Improve Bispecific T-Cell Engagers for Solid Tumor Therapy (Poster
  presented at AACR Annual Meeting 2026)\nThe start time has not been annou
 nced.\nWebcast: https://investors.hcwbiologics.com/events/event-details/de
 velopment-hcw11-018b-t-cell-engager-innovative-approach-improve-bispecific
 -t
END:VEVENT
BEGIN:VEVENT
UID:60cf7312-f050-49fe-b915-bf6e40532c3d@equibles.com
DTSTAMP:20260617T191047Z
DTSTART;VALUE=DATE:20260514
DTEND;VALUE=DATE:20260515
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:HCW Biologics Inc. (HCWB) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
END:VCALENDAR